Hongyi Fu

Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease.

Yugang Wang, Min Shi, Hongyi Fu, 2010, Molecular medicine reports.

HAX-1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation.

Hongyi Fu, Jian Zhu, Hui Xu, 2015, International journal of clinical and experimental pathology.